These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27272255)

  • 41. 4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy.
    Xue C; Nie W; Zhou C; Yu F; Wang DM; Dai B; Mei CL
    Ren Fail; 2014 Apr; 36(3):332-8. PubMed ID: 24345290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
    Zhang TT; Yuan L; Yang YM; Ren Y
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasminogen activator inhibitor-1 activity and 4G/5G polymorphism in hemodialysis.
    Trimarchi H; Duboscq C; Genoud V; Lombi F; Muryan A; Young P; Schwab M; Castanon M; Rodriguez-Reimundes E; Forrester M; Pereyra H; Campolo-Girard V; Seminario O; Alonso M; Kordich L
    J Vasc Access; 2008; 9(2):142-7. PubMed ID: 18609532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
    Wiwanitkit V
    Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.
    Shammaa DM; Sabbagh AS; Taher AT; Zaatari GS; Mahfouz RA
    Mol Biol Rep; 2008 Sep; 35(3):453-7. PubMed ID: 17578681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies.
    Zheng L; Li X; Song Q; Hou C; Chen X; Li B
    Int Arch Allergy Immunol; 2019; 180(4):255-263. PubMed ID: 31574527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between PAI-1 -675 4G/5G polymorphism and type 2 diabetes mellitus.
    Chen L; Li SY; Liu M
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):66-68. PubMed ID: 28838342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D; Yurdakök M; Okur H; Gürgey A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications: a meta-analysis of fifty-one case-control studies.
    Chen J; Zhai C; Wang Z; Li R; Wu W; Hou K; Alzogool M; Wang Y; Cong H
    BMC Endocr Disord; 2021 Sep; 21(1):195. PubMed ID: 34592988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.
    Rossaak JI; Van Rij AM; Jones GT; Harris EL
    J Vasc Surg; 2000 May; 31(5):1026-32. PubMed ID: 10805895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome.
    Luo Y; Wang C; Tu H
    Mol Med Rep; 2014 Mar; 9(3):894-8. PubMed ID: 24435552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.